SUNSHINE BIOPHARMA INC (SBFM) Stock Income Statement
NASDAQ:SBFM - Nasdaq - US8677817004 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.23M | 34.87M | 24.09M | 4.35M | 228.00K | |||
| Cost Of Goods | 25.19M | 24.20M | 15.75M | 2.65M | 118.00K | |||
| Gross Profit | 11.05M | 10.67M | 8.34M | 1.70M | 111.00K | |||
| Operating Expenses | 16.75M | 16.48M | 13.12M | 10.37M | 2.55M | |||
| Research and Development | 927.20K | 933.90K | 1.86M | 812.00K | 672.00K | |||
| Selling, General, and Administrative Expenses | 15.58M | 15.32M | 11.12M | 8.96M | 1.87M | |||
| Operating Income | -5.71M | -5.81M | -4.79M | -8.67M | -2.44M | |||
| Interest Income/Expense | 380.70K | 443.20K | 674.00K | 479.00K | -321.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | -18.32M | -9.68M | |||
| Income Before Taxes | -5.33M | -5.37M | -4.11M | -26.51M | -12.44M | |||
| Income Tax | -297.40K | -234.90K | 395.00K | 233.00K | 0.00 | |||
| Net Income | -5.03M | -5.13M | -4.51M | -26.74M | -12.44M | |||
| EBITDA | -5.46M | -5.59M | -4.64M | -8.65M | -2.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -12.33 | -7.32 | -18.54 | -175.94 | -478.30 | |||
| Non GAAP EPS | N/A | -51.88 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 30.48% | 30.60% | 34.61% | 39.05% | 48.68% | |||
| Profit Margin | -13.88% | -14.72% | -18.70% | -615.37% | -5454.39% | |||
| Operating Profit Margin | -15.75% | -16.67% | -19.86% | -199.59% | -1070.61% | |||
All data in USD